Cancer Treatment
Studies from the United States and Italy add new findings to cancer treatment body of knowledge
Published in Vaccine Weekly, May 31st, 2006
Study 1: The recombinant immunotoxin LMB-2 selectively eliminates human regulatory T lymphocytes.
"CD4+CD25+ T-regulatory cells (Treg ) can inhibit the proliferation and cytokine secretion of CD4+CD25- helper T cells in mice and humans. In murine tumor models, the presence of these Treg cells can inhibit the antitumor effectiveness of T-cell transfer and active immunization approaches. We have thus initiated efforts to eliminate Treg cells selectively from human peripheral blood mononuclear cells (PBMCs) to potentially bolster...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-05-31)
More Articles from Vaccine Weekly
- Chancroid Vaccine
Haemophilus ducreyi hemoglobin receptor protects against chancroid - Drug Development
Directed antigen delivery is vaccine strategy for intracellular bacterial pathogens - Environmental Health
Soot immunization elicits antibodies against polycyclic aromatic hydrocarbons - Epidemiology
Pneumococcal conjugate vaccine reduces invasive pneumococcal disease among infants - Pneumococcal Vaccine
DNA vaccines expressing pneumococcal surface protein A are as protective as recombinant protein - Alzheimer Disease
Anti-A-beta antibodies do not prevent neurofibrillary tangle formation - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
